Streetbeat News

Regulatory

AN

CDK

AutoNation was notified by CDK Global of a cyber incident affecting its dealer management system. AutoNation has taken precautionary steps and is reviewing the impact.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:07 am

RGNX

REGENXBIO has announced the expansion of its AFFINITY DUCHENNE trial to include a new cohort of younger patients. This move aims to broaden the scope of the trial and potentially accelerate the development of treatments for Duchenne Muscular Dystrophy.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:06 am

HRMY

Harmony Biosciences has received FDA approval for a supplemental new drug application for WAKIX, which is expected to enhance its market position and potentially increase revenues.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:05 am

CANF

Can-Fite BioPharma Ltd. (NYSE:CANF) announced breakthrough findings on Namodenoson's dual anti-cancer and liver protective effects, mediated by the signalling protein adiponectin. These findings will be presented at the IDDST-2024 conference in Shanghai. Namodenoson is currently in Phase III and Phase IIb clinical trials for advanced liver cancer and MASH, respectively.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:04 am

AXGN

Axogen, Inc. (NASDAQ:AXGN) has launched a new product, Avive+ Soft Tissue Matrix, designed to aid in nerve healing. This product is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing. The product complies with FDA regulations and aims to address a significant need in the $800 million nerve protection market.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:03 am

BNTX

BioNTech and Duality Biologics announced that the FDA has granted Fast Track Designation for BNT324/DB-1311 for advanced or metastatic castration-resistant prostate cancer patients who have progressed on or after standard systemic regimens.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 11:02 am

ALNY

Trading in ALNY was halted at 6:55:00 a.m. ET pending news. Investors should stay tuned for updates as the halt indicates significant news is forthcoming.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:55 am

BA

ITA

PPA

Boeing Co (NYSE:BA) risks potential criminal charges as U.S. prosecutors reportedly recommend legal action against the company for allegedly breaching a 2021 deferred prosecution agreement following two fatal 737 MAX crashes. The Justice Department has until July 7 to decide on prosecuting Boeing, which could result in significant penalties. Boeing has denied any wrongdoing, but discussions with the Justice Department are ongoing. The stock has lost more than 14% in the last 12 months. Investors can gain exposure to Boeing via IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Invesco Aerospace & Defense ETF (NYSE:PPA).

Portfolio Pulse from Shivani Kumaresan

June 24, 2024 | 10:47 am

NXE

NexGen Energy's Rook I Project is advancing as the Canadian Nuclear Safety Commission (CNSC) reviews the final Environmental Impact Statement (EIS). The CNSC has started a 60-day technical review, after which a Federal Commission Hearing date will be set. NexGen is ready to commence major construction upon receiving the remaining approvals.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:37 am

EMBC

Embecta Corp. (NASDAQ:EMBC) presented data at the American Diabetes Association's 84th Scientific Sessions highlighting the benefits of a new diabetes patch pump with a larger, 300-unit insulin reservoir. The data suggests that this larger reservoir could improve insulin management for adults with type 2 diabetes by providing longer wear times and reducing the number of disposable patches needed.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:33 am